Abstract:Background SUMOylation is an important component of post-translational protein modifications (PTMs), and bladder cancer (BCa) is the ninth most common cancer around the world. But the comprehensive role of SUMOylation in shaping tumor microenvironment (TME) and influencing tumor clinicopathological features and also the prognosis of patients remains unclear. Methods Using the data downloaded from The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO), we comprehensively evaluated the SUMOylation patterns of 570 bladder cancer samples, and systematically correlated these SUMOylation patterns with TME immune cell infiltrating characteristics. The SUMO score was constructed to quantify SUMOylation patterns of individuals using principal component analysis (PCA) algorithms. Results Two distinct SUMOylation patterns and gene clusters were finally determined. Significant differences in the prognosis of patients were found among two different SUMOylation patterns and gene clusters, so were in the mRNA transcriptome and the landscape of TME immune cell infiltration. We also established a set of scoring system named SUMO score to quantify the SUMOylation pattern of individuals with BCa, which was discovered to be tightly connected with tumor clinicopathological characteristics and could predict the prognosis of patients with BCa. Moreover, SUMO score was a considerable predictive indicator for the survival outcome independent of tumor mutation burden (TMB) and low SUMO score was related to better response to immunotherapy using PD-1 blockade. We also found that there existed a significant relationship between sensitivity to commonly used chemotherapy drugs and SUMO score. Finally, a nomograph based on five features, namely, SUMO score, age, gender, T category, and M category was constructed to predict the survival probability of patients with BCa in 1, 3, and 5 years, respectively. Conclusions Our work demonstrated and overviewed the complicated regulation mechanisms of SUMOylation in bladder cancer, and better understanding and evaluating SUMOylation patterns could be helpful in guiding clinical therapeutic strategy and improving the prognosis of patients with BCa.

SUMOylation Wrestles With the Occurrence and Development of Breast Cancer

Post-Translational Modification of SUMOylation and Cancer: A Brief Review

Crosstalk between SUMOylation and other post-translational modifications in breast cancer

Sumoylation As an Emerging Target in Therapeutics Against Cancer

The post-translational modification, SUMOylation, and cancer (Review)

Advances in Research on Sumoylation of Breast Cancer-Related Proteins

Sumoylation as an Emerging Target in Therapeutics against Cancer.

SUMOylation Homeostasis in Tumorigenesis

Small-Molecule Inhibitors Targeting Protein SUMOylation As Novel Anticancer Compounds.

The SUMO Family: Mechanisms and Implications in Thyroid Cancer Pathogenesis and Therapy

Research progression in post-translational protein modification sumoylation in cancer

The Emerging Roles of SUMOylation in the Tumor Microenvironment and Therapeutic Implications

Protein SUMOylation Modification and Its Associations with Disease

SUMOylation: A Link to Future Therapeutics.

Comprehensive Analysis of the SUMO-related Signature: Implication for Diagnosis, Prognosis, and Immune Therapeutic Approaches in Cervical Cancer

The Important Roles of Protein SUMOylation in the Occurrence and Development of Leukemia and Clinical Implications

SUMOylation Pattern Predicts Prognosis and Indicates Tumor Microenvironment Infiltration Characterization in Bladder Cancer

SUMO and the robustness of cancer

Roles of SUMOylation and De-Sumoylation in Carcinogenesis

Therapeutic Potential of Targeting the SUMO Pathway in Cancer

The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells